By Dean Seal Kazia Therapeutics' American depositary shares tumbled after the company agreed to a $2 million registered direct offering that prices shares at.
By Dean Seal Structure Therapeutics' American depositary receipts surged after the company delivered positive results for its weight-loss drug and disclosed.